The latest pharma news from Southeast Asia, including the Singaporean Health Sciences Authority (HSA) being awarded the highest maturity level in the WHO’s classification of global regulatory authorities, as well as highlights from Indonesia, the Philippines, and Malaysia Singapore…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for COVID-19 vaccine distributors; and Moderna’s CMO-based vaccine manufacturing strategy in…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest pharma and healthcare news from Southeast Asia, including the partnership between KPJ Healthcare and Samsung; Specialised Therapeutics’ immuno-oncology therapy; Singapore biotech CytoMed Therapeutics’ IPO, the Malaysian approval of…
Saanjay Shamdasany, Director of Government Affairs & Public Policy at Baxter and Head of the Pharmaceutical and Life Sciences Committee at American Chamber of Commerce Indonesia, explains the importance of the collaboration between international healthcare companies and the national government to enhance the Indonesian healthcare system. Mr. Sanjaay, could you please introduce yourself to our international audience? “In my opinion,…
Suryo Suwignjo, President Director at Philips Indonesia, highlights the strong commitment and contribution of Philips to the development of the Indonesian healthcare system and how medical education is a crucial…
Rufi Susanto, President (Core Market) and Senior Managing Director IDS Medical Systems (idsMED), highlights the company’s commitment to Indonesia and believes that idsMED’s employees, in combination with continuous investment in…
The latest pharma and healthcare news from Southeast Asia, including the proposed healthcare programs of Thailand’s political parties for the upcoming election; Singapore’s approval of Pfizer’s 20-valent pneumococcal conjugate vaccine;…
Takeda gets a first approval for QDENGA, its dengue vaccine, which has been given the green light by the Indonesian National Agency for Drug and Food Control, Badan Pengawas Obat…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
After gaining its first global approval in Indonesia, Takeda’s dengue fever vaccine, Qdenga, recently got a green light from the European Commission (EC) to market the vaccine in Europe, laying…
With a market value of USD 5.2 billion, Kalbe Farma has consolidated into Indonesia’s undisputed national pharma champion and has established a footprint in many ASEAN countries as well as…
The latest pharma and healthcare news from APAC, including Celltrion’s plans to sell its Takeda portfolio to CBC; reforms to the South Korean national insurance system that may lead to…
See our Cookie Privacy Policy Here
